Severe bone marrow depression induced by an anticancer herb Cantharanthus roseus

Journal of Toxicology - Clinical Toxicology

Volumn 42, Issue 5, 2004, Pages 667-671

  Wu, Ming Ling ^a   Deng, Jou Fang ^a   Wu, Jaw Ching ^a   Fan, Frank S ^a   Yang, Ching Fen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bone marrow suppression; Cantharanthus roseus; Drug interaction; Herbal poisoning; Vinca alkaloids

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CATHARANTHUS ROSEUS EXTRACT; CISAPRIDE; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; HERBACEOUS AGENT; PLANT EXTRACT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; VINCA ALKALOID;

AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOLYSIS; BEVERAGE; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; CASE REPORT; CATHARANTHUS ROSEUS; CELL INFILTRATION; DISEASE SEVERITY; DRUG METABOLISM; FEMALE; HEMATOPOIETIC CELL; HEPATITIS C; HUMAN; INTOXICATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PANCYTOPENIA; TRADITIONAL MEDICINE;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOCYNACEAE; BONE MARROW DISEASES; CARCINOMA, HEPATOCELLULAR; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE COUNT; FEMALE; GASTROINTESTINAL DISEASES; HEPATITIS C; HUMANS; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; LIVER NEOPLASMS; PANCYTOPENIA; PLATELET COUNT;

CATHARANTHUS ROSEUS; HEPATITIS C VIRUS; POMACANTHUS MACULOSUS; VINCA;

EID: 4644273573     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-200026963     Document Type: Article

References (10)

1. Chiu NY, Chang KH. The Illustrated Medicinal Plants of Taiwan. Vol. 1. 4th ed. Taipei: SMC Publishing Inc., 1983:156.
2. Dewick PM. Tumor inhibitors from plants. In Trease and Evan's Pharmacognosy. 14th ed. Evans W C, ed. London: WB Saunders Company, 1996: 420-422.
3. Johnson JS, Armstrong JG, Gorman M, Burnett JP. The vinca alkaloids: a new class of oncolytic agents. Cancer Res 1963; 23:1390-1427.
4. Kao PC. New Edition of Chinese Medicine Dictionary. Taipei: Hsin Wen Feng Publishing Company, 1985:2217-2219.
5. Calabresi P, Chabner BA. Antineoplastic agents: vinca alkaloids. In: Hardman JG, Limbird LE, Gilman AG, eds. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill Companies, 2001:1417-1419.
6. Noble RL. The discovery of the vinca alkaloids-chemotherapeutic agents against cancer. Biochem Cell Biol 1990; 68(12):1344-1351.
7. Kivisto KT, Kroemer HK, Eichelbaum M. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 1995; 40(6):523-530.
8. Yao D, Ding S, Burchell B, Wolf CR, Friedberg T. Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance. J Pharmacol Exp Ther 2000; 294(1):387-395.
9. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000; 38(1):41-57.
10. Vincristine and Vinblastine. Drugdex: 1974-2004. Vol. 120. Thomson Micromedex Inc., 2004.